维普期刊资源整合服务平台（V6.5）

35篇 您的检索式：作者名="MITA A C"

选中清除导出查看参考文献查看引证文献引用追踪共2页首页上一页第1页下一页末页 /2 跳转

	题名	作者	年代	出处	被引量
1	survivin: key regulator of mitosis and apoptosis and novel target for cancer therapeutics 显示文摘	Mita A C Mita M M Nawrocki S T	2008	Clin Cancer Res2008，14，16：	1
2	Survivin : key regulator of mitosis and apoptosis and novel target for cancer therapeutics显示文摘	Mita A C Mita M M Nawroki S T	2008	Clin Cancer Res2008，14，6：	1
3	Early warning of hazard for pipelines by acoustic recognition using principal component analysis and one-class support vector machines显示文摘	Wan C F Mita A	2010	Smart Structures and Systems2010，6，4：	1
4	Survivin: key regulator of mitosis and apoptosis and novel target for cancer therapeutics显示文摘	MITA A C MITA M M NAWROCKI S T	2008	Clin Cancer Res2008，14，16：	1
5	Survivin:key regulator of mitosis and apoptosis and novel target for cancer thera-peutics显示文摘	MITA A C MITA M M NAWBOCKI S T	2008	Clin Cancer Res2008，14，16：	1
6	Survivin: key regulator of mitosis and apoptosis and novel target for cancer therapeutics显示文摘	MITA A C MITA M M NAWROCKI S T	2008	Clin Cancer Res2008，14，16：	1
7	Heat shock proteins:a potential anticancer target显示文摘	Sankhala K K Mita M M Mita A C Takimoto C H	2011	Curr Drug Targets2011，12，：	1
8	Survivin: key regulator of mitosis and apoptosis and novel target for cancer therapeutics 显示文摘	MITA A C MITA M M NAWROCKI S T	2008	Clin Cancer Res2008，14，：	1
9	Clinical outcome in patients with intermediate sterosis of left anterior descending coronary artery after deferral of revascularization on the basis of noninvasive coronary flow reserve measurement显示文摘	D'Andrea A Severino S Mita C	2009	Echocardiography2009，26，4：	1
10	Survivin:key regulator of mitosis and apoptosis and novel target for cancer therapeutics显示文摘	Mita A C Mita M M Nawrocki ST	2008	Clin Cancer Res2008，14，16：	1
11	Phase 1 study of AMG 386, a selective angiopoietin 1/2-neutralizing peptibody, in combination with chemotherapy in adults with advanced solid tumors 显示文摘	Mita A C Takimoto C H Mita M	2010	Clin Cancer Res2010，16，11：	1
12	Clinical outcome in patients with intermediate stenosis of left anterior descending coronary artery after deferral of revascularization on the basis of noninvasive coronary flow reserve measurement显示文摘	D'Andrea A Severino S Mita C	2009	Echocardiography2009，26，4：	1
13	Purification method using iodixanol (OptiPrep)-based density gradient significantly reduces cytokine ebemokine production from human islet preparations, leading to prolonged beta-cell survival during pretransplantation culture显示文摘	Mita A Ricordi C Miki A	2009	Transplant Proc2009，41，1：	1
14	Survivin:Key regulator of mitosis and apoptosis and novel target for cancertherapeutics显示文摘	Ahieri D C Marchisio P C Mita A C	2008	Clin Cancer Res2008，14，16：	1
15	Survivin:key regulator of mitosis and apop-tosis and novel target for cancertherapeutics 显示文摘	Mita A C Mita M M Nawrocki S T	2008	Clin Cancer Res2008，14，16：	1
16	Antiproinflammatory effects of iodixanol (OptiPrep) -based density gradient purification on human islet preparations显示文摘	Mita A Ricordi C Messinger S	2010	Cell Transplant2010，19，12：	1
17	Purification method using iodixauol (optiprep)-based density gradient significantly reduces cytokine chemokine production from human islet preparations, leading to prolonged beta-cell survival during pretransplantation culture 显示文摘	Mita A Rieordi C Miki A	2009	Transplantation Proceedings2009，41，1：	1
18	Phase Iand pharmacokinetic study of XRP6258(RPR116258A),a novel taxane,administered as a 1-hour infusion every 3 weeks in patients with advanced solid tumors显示文摘	Mita A C Denis L J Rowinsky E K	2009	Clin Cancer Res2009，15，2：	1
19	Recombinant lipoxygenases as bioeatalysts for natural flavour production显示文摘	Gallo A Mita G Zasiura C	2001	Meded Rijksuniv Gent Fak Landbouwkd Toegep Biol Wet2001，66，：	1
20	Survivin:key regulator of mitosis and apoptosis and novel target for cancer therapeutics显示文摘	Mita A C Mita M M Nawrocki S T	2008	Clin Can Res2008，14，16：	1

返回顶部每页显示：

共2页首页上一页第1页下一页末页 /2 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示